Beware of scams

We are aware of scams coming from email and social media where people try to impersonate us. We will never ask you for money or your bank details.

Learn more about what to look out for and how to protect yourself

What we do

British Patient Capital invests in best-in-class venture and venture growth capital fund managers with a strong UK focus, as well as directly in the most promising later-stage businesses.

As the UK’s largest domestic investor in UK venture and venture growth opportunities, we are increasing access to, and the availability of, long-term, patient finance. We do this via three schemes, each one addressing specific market issues.

Across all its activities, British Patient Capital invests on a commercial basis to deliver competitive returns for the UK taxpayer. By demonstrating that a patient capital approach can produce commercially attractive returns, we are encouraging other UK institutional investors to invest in the asset class, to both drive and benefit from the success of our high-growth companies.

Learn more about what British Patient Capital do

Future Fund: Breakthrough

Future Fund: Breakthrough is a £425m UK-wide programme which encourages private investors to co-invest in growth stage, Research & Development (R&D) UK companies operating in breakthrough technology sectors.

Learn more about Future Fund: Breakthrough